Venous thromboembolism (VTE) has a wide range of clinical presentations. Deep venous thrombosis may occur in upper or lower extremities or in visceral veins. Extremity deep venous thrombosis usually manifests with unilateral painful swelling in the limb, while visceral deep venous thrombosis manifestations vary on the basis of the involved organ. Pulmonary embolism classically manifests with sudden pleuritic chest pain and unexplained dyspnea. Superficial thrombophlebitis usually presents with acute inflammation around a palpable thrombosed superficial vein. Risk factors of VTE are either inherited or acquired. The inherited causes of VTE tend to be familial and more common in younger patients. The common acquired risk factors of VTE include previous history of venous thrombosis, immobilization, recent surgery or trauma, malignancy, and pregnancy. Identifying high-risk patients for VTE based on these risk factors is the cornerstone to provide the prophylactic treatment to prevent thrombotic events.
Chest x-rays (CXR) are the most frequent radiological tests performed in the intensive care unit (ICU). Proposed advantages of daily routine CXR are early detection & thus earlier treatment of clinically unsuspected abnormalities, documentation of disease progression and response to therapy, and detection of complications associated with indwelling devices. Proposed disadvantages include, variable interpretation of CXR depending on clinician and patient factors, low incidence of clinically unsuspected abnormalities, potential harm arising from unnecessary treatment of minor or false positive findings, cost, radiation exposure and adverse events arising from repositioning of the patient to obtain the CXR. Anecdotal reports suggest that more routine daily CXR are performed in the Allegheny General Hospital (AGH) medical intensive care unit (MICU) than what is necessary. A review of the literature suggests (and a consensus statement by the American College of Radiology concurs) that routine daily chest radiographs in the ICU are not indicated. The American Thoracic Society also agrees that routine chestradiography is rarely indicated and may be harmful. Unexpected findings on chest radiographs were noted in <6% of the 2457 daily routine radiographs ordered in 754 consecutive ICU patients in a mixed medical-surgical ICU. The unexpected CXR findings prompted a change in management in less than half of these cases. Stable patients are particularly unlikely to benefit from routine chest radiography. Our mission was to determine if routine daily CXR is beneficial in the MICU and to determine how often the CXR prompted a major intervention. METHODS: We reviewed 242 consecutive CXRs obtained at AGH MICU and the consequent management changes in 60 ICU patients. The indications for the CXRs, significant changes observed on the x-ray, and x-rays performed after procedures were also computed. RESULTS: Twenty-four out of 242 (9.9%) CXRs had significant changes as determined by a radiologist. Thirty-three out of 242 (13.6%) management changes occurred. Out of the management changes, only 18 of 242 (7.4%) involved major procedures like bronchoscopy, repositioning of tubes, or chest tube placement/thoracentesis. Twenty-seven of 242 (11.2%) x-rays were for tube adjustment/insertion, and 24 of 242 (9.9%) were for line placement. CONCLUSIONS: More CXRs than necessary are still ordered in the MICU. 9 out of 10 times, there were no significant changes and results from only about 1 in 13 CXRs required major procedures. CLINICAL IMPLICATIONS: We should use clinical assessment to determine whether to order CXR. Routine daily CXR in the MICU is rarely beneficial, and physicians should carefully reconsider the clinical need for routine daily chest x-rays.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.